Is Hangzhou Biotest Biotech stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Hangzhou Biotest Biotech pays dividends. Last time was Tuesday 11th of June 2024 where the investors holding the stock on Tuesday 11th of June 2024 were paid CNY0.8 per share. Over the last 3 times between 2022 and 2024, Hangzhou Biotest Biotech has paid CNY6 with an average of CNY2 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Hangzhou Biotest Biotech 10 years ago, but if you had invested on Wednesday 8th of September 2021 when the price was CNY77.13, you would have made a loss of CNY-52.65 per share or -68.26%
Yes, the average daily trading liquidity for Hangzhou Biotest Biotech is CNY466 650 thousand. You should therefore be able to get in and out of your positions relatively fast.
Hangzhou Biotest Biotech has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 97.15, the company's ability to pay off the debt is good. Hangzhou Biotest Biotech has a very good net profit margin of 28.34% and should have very high tolerances against inflation.
We have calculated the inflation risk for Hangzhou Biotest Biotech to be low [0 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.